An experimental mRNA cancer drug has been found to stop the spread and return of melanoma for the first time, a potentially game-changing breakthrough for people with life-threatening skin cancer.
The vaccine, called intismeran, which is personalized for each patient, succeeded in preventing melanoma from coming back or spreading in people who had surgery to remove the cancer when combined with another cancer drug, Keytruda, the drugmakers Merck and Moderna announced Wednesday.
